Teicoplanin in cardiac surgery: Intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1150-1155

  Martin, Claude ^a   Bourget, Philippe ^b   Alaya, Majed ^d   Sertin, Anthony ^b   Atlani, Caroline ^c   Ennabli, Karim ^d   Said, Rachid ^d  

^a HÔPITAL NORD   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Marion Merrell Dow SA   (France)

^d SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; AORTA CLAMPING; AREA UNDER THE CURVE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG PENETRATION; DRUG TISSUE LEVEL; HEART SURGERY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MEAN RESIDENCE TIME; MEDIASTINUM; MINIMUM INHIBITORY CONCENTRATION; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STERNUM;

EID: 0030978238     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1150     Document Type: Article

References (20)

1. Bannerman, T. L., D. L. Wadiak, and W. E. Kloos. 1991. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob. Agents Chemother. 35:1919-1922.
2. Bergamini, T. M., and M. C. Polk. 1989. The importance of tissue antibiotic activity in the prevention of operative wound infection. J. Antimicrob. Chemother. 23:301-313.
3. Classen, D. C., S. Evans, S. L. Pestotnik, S. D. Horn, R. L. Menlove, and J. P. Burke. 1992. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 326:281-286.
4. de Lalla, F., A. Novelli, G. Pellizzer, F. Milocchi, R. Viola, A. Rigon, C. Stecca, V. Dal Pizzol, S. Fallani, and P. Periti. 1993. Regional and systemic prophylaxis with leicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob. Agents Chemother. 37:2693-2698.
5. Entenza, J. M., T. Calandra, Y. Moosman, R. Malinverni, and M. P. Glauser. 1992. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats. Antimicrob. Agents Chemother. 36:1256-1262.
6. Gorinski, E. A., D. Amsterdam, T. R. Beam, Jr., and C. Rotstein. 1989. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci. Antimicrob. Agents Chemother. 33:2019-2022.
7. Greenberg, R. N., and C. A. Benes. 1990. Time-kill studies with oxacillin, vancomycin and teicoplanin versus Staphylococcus aureus. J. Infect. Dis. 161: 1036-1037.
8. Hoddinott, C., A. M. Levering, H. C. Fernando, J. H. Dixon, and D. S. Reeves. 1990. Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty. J. Antimicrob. Chemother. 26:823-829.
9. Jehl, F., H. Monteil, and A. Tarral. 1988. HPLC quantification of the six main components of teicoplanin in biological fluids. J. Antimicrob. Chemother. 21:53-59.
10. Klamerus, K. J., K. A. Rodvold, N. A. Silverman, and S. Levitsky. 1988. Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition. Antimicrob. Agents Chemother. 32:631-635.
11. Lorian, V. 1985. Low concentrations of antibiotics. J. Antimicrob. Chemother. 15(Suppl. A):15-26.
12. Martin, C., M. Alaya, M. N. Mallet, X. Viviand, K. Ennabli, R. Said, and P. De Micco. 1994. Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob. Agents Chemother. 38:396-399.
13. Moreillon, P., P. Francioli, D. Overholzer, P. Meylan, and M. P. Glauser. 1986. Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis. J. Infect. Dis. 154:801-807.
14. Mutch, D. G., R. A. Richards, and D. S. Mudler. 1982. Bioactive antibiotic levels in the human aorta. Surgery 92:1068-1071.
15. Pitkin, D. M., C. Sachs, I. Zajac, and P. Actor. 1977. Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits. Antimicrob. Agents Chemother. 11:760-762.
16. Pitt, M. A., R. B. Roberts, and W. D. Johnson. 1973. Gentamicin levels in the human biliary tract. J. Infect. Dis. 127:299-302.
17. Rowland, M., and T. Tozer. 1980. Clinical pharmacokinetics: concept and application. Lea & Febiger, Philadelphia, Pa.
18. Stanbridge, T. N., and D. J. B. Greenall. 1984. Netilmicin prophylaxis in open-heart surgery. J. Antimicrob. Chemother. 13(Suppl. A):59-66.
19. Stone, H. H. 1984. Basic principles in the use of prophylactic antibiotics. J. Antimicrob. Chemother. 14(Suppl. B):33-37.
20. Wilson, A. P. R., B. Taylor, T. Treasure, R. N. Gruneberg, K. Patton, D. Felmingham, et al. 1988. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J. Antimicrob. Chemother. 21:201-212.